The present invention relates generally to molecular mechanisms of
mTOR-related human diseases. More specifically, the invention relates to
two novel related polypeptides, the ER-localization sequence (ELS) and
Golgi-localization sequence (GLS) along with therapeutic, diagnostic and
research utilities for these polynucleotides and proteins.